All Stories

  1. Cardiovascular Disease and Frailty: What Are the Mechanistic Links?
  2. Psychosocial stress and major cardiovascular events in patients with stable coronary heart disease
  3. Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
  4. Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
  5. Self‐Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
  6. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease
  7. Lipoprotein‐Associated Phospholipase A2Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
  8. Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
  9. A new process for creating points systems for prioritising patients for elective health services